Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 21 November 2014 |
| Author/s |
author: Waldemar Halota |
| Publication date | November 21, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |